Bezafibrate Increases Preβ1-HDL at the Expense of HDL 2b in Hypertriglyceridemia
Authors:
- 1 November 2000
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 20 (11) , 2428-2433
Abstract
—Preβ1-high density lipoprotein (preβ1-HDL), the initial acceptor of cell-derived cholesterol, can be generated from HDL 2 by hepatic lipase. Because bezafibrate elevates lipase activity, it may increase preβ1-HDL at the expense of HDL 2 . To answer this question, we determined the apolipoprotein A-I (apoA-I) distribution in 20 hypertriglyceridemics (triglycerides>2.26 mmol/L) and 20 sex-matched normolipidemics by native 2-dimensional gel electrophoresis. At baseline, preβ1-HDL was 70% higher in hypertriglyceridemics than in normolipidemics (123.5±49.9 versus 72.5±34.1 mg/L apoA-I, P r =0.624, P P 2b by 31% (from 188.8±94.9 to 129.3±78.7 mg/L apoA-I, P P 2 or from plasma during incubation with triglyceride lipase. In conclusion, bezafibrate increases preβ1-HDL at the expense of HDL 2 . We speculate that such an effect might partly contribute to the antiatherogenic action of bezafibrate.Keywords
This publication has 25 references indexed in Scilit:
- Serum Amyloid A Protein Generates Preβ1 High-Density Lipoprotein from α-Migrating High-Density LipoproteinBiochemistry, 1999
- Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-β1 migrating particles and decreases LCAT activationAtherosclerosis, 1998
- High preβ1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol dietAtherosclerosis, 1998
- LpA-I levels do not reflect preβ1-HDL levels in human plasmaAtherosclerosis, 1997
- Pathway of cholesterol efflux from human hepatoma cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemiaAtherosclerosis, 1994
- Mechanism of transfer of LDL-derived free cholesterol to HDL subfractions in human plasmaBiochemistry, 1990
- Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrumAtherosclerosis, 1990
- Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoproteinBiochemistry, 1988
- Elevated lipoprotein lipase activity in skeletal muscle tissue during treatment of hypertriglyceridaemic patients with bezafibrateAtherosclerosis, 1982